Zai Lab Ltd Investor Day Transcript
All right. Good morning, good afternoon and good evening to those listening around the world. My name is Billy Cho, CFO of Zai Lab. We're thrilled to be in New York today for our first ever Investor Day. At Zai Lab, we are at a pivotal moment poised for significant growth with multiple key value drivers coming over the near term. And this Investor Day serves to showcase our capabilities, strategy and ambitious goals that we believe will shape the future of Zai Lab and the industry.
Next slide, please. Presenting today are Dr. Samantha Du, our Founder and Chief Executive Officer; Dr. Rafael Amado, our Head of Global Oncology, R&D.; Dr. Harald Reinhart, our Head of Global Development for neuroscience, autoimmune and infect diseases; Dr. William Liang, our Chief Commercial Officer; Josh Smiley, our President and Chief Operating Officer; and Jonathan Wang, our Chief Business Officer. In addition, Dr. Peter Huang, our Chief Scientific Officer, will be joining us for Q&A. We also have several important KOLs from China joining us to provide more insights into
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |